Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC

K. D. Joode, H. J. M. Groen, A. A. M. van der Veldt, K. P. M. Suijkerbuijk, J. W. B. de Groot, R. de Wijn, D. P. Hurkmans, D. M. A. van den Heuvel, K. Schmidt, J. P. Groten, E. M. E. Verdegaal, S. H. van der Burg, M. M. van den Heuvel, J. G. J. V. Aerts, E. Kapiteijn, R. H. Mathijssen

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Pages (from-to)S788-S788
    Number of pages1
    JournalAnnals of Oncology
    Volume31
    DOIs
    Publication statusPublished - Sept-2020
    EventESMO Virtual Congress -
    Duration: 19-Sept-202018-Oct-2020

    Cite this